CoChat

Vascular disease and dementias: Paradigm shifts to drive research in new directions

Open access
Kling, Mitchel A., Trojanowski, John Q., Wolk, David A., Lee, Virginia M.Y., Arnold, Steven E. · 2013 · Alzheimer's & Dementia
Cited by 133

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Vascular disease was once considered the principal cause of aging‐related dementia. More recently, however, research emphasis has shifted to studies of progressive neurodegenerative disease processes, such as those giving rise to neuritic plaques, neurofibrillary tangles, and Lewy bodies. Although these studies have led to critical insights and potential therapeutic strategies, interest in the role of systemic and cerebrovascular disease mechanisms waned and has received relatively less attention and research support. Recent studies suggest that vascular disease mechanisms play an important role in the risk for aging‐related cognitive decline and disorders. Vascular disease frequently coexists with cognitive decline in aging individuals, shares many risk factors with dementias considered to be of the “Alzheimer type,” and is observed more frequently than expected in postmortem material from individuals manifesting “specific” disease stigmata, such as abundant plaques and tangles. Considerable difficulties have emerged in attempting to classify dementias as being related to vascular versus neurodegenerative causes, and several systems of criteria have been used. Despite multiple attempts, a lack of consensus remains regarding the optimal means of incorporating vascular disease into clinical diagnostic, neurocognitive, or neuropathologic classification schemes for dementias. We propose here an integrative, rather than a strictly taxonomic, approach to the study and elucidation of how vascular disease mechanisms contribute to the development of dementias. We argue that, instead of discriminating between, for example, “Alzheimer's disease,” “vascular dementia,” and other diseases, there is a greater need to focus clinical and research efforts on elucidating specific pathophysiologic mechanisms that contribute to dementia phenotypes and neuropathologic outcomes. We outline a multitiered strategy, beginning with clinical and public health interventions that can be implemented immediately, enhancements to ongoing longitudinal studies to increase their informative value, and new initiatives to capitalize on recent advances in systems biology and network medicine. This strategy will require funding from multiple public and private sources to support collaborative and interdisciplinary research efforts to take full advantage of these opportunities and realize their societal benefits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2012.02.007

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 123

  1. 10.1016/S0140-6736(09)61460-4 · DOI · Paper page
  2. 10.2307/3350025 · DOI · Paper page
  3. 10.1016/j.jalz.2010.01.010 · DOI · Paper page
  4. 10.1007/s00401-006-0185-2 · DOI · Paper page
  5. Cavalieri M., 2010, Vascular dementia and Alzheimer's disease—are we in a dead‐end road?, Neurodegener Dis, 7, 122, 10.1159/000285521 · DOI
  6. 10.1136/jnnp.54.12.1122 · doi:10.1136/jnnp.54.12.1122
  7. Libon D.J., 2009, Neurovascular Neuropsychology, 75, 10.1007/978-0-387-70715-0_6 · DOI
  8. Roman G.C., 1999, A historical review of the concept of vascular dementia: lessons from the past for the future, Alzheimer Dis Assoc Disord, 13, S4, 10.1097/00002093-199912001-00002 · DOI
  9. Roman G.C., 2003, Vascular Cognitive Impairment: Preventable Dementia, 12, 10.1093/oso/9780192632678.003.0002 · doi:10.1093/oso/9780192632678.003.0002
  10. McMenemey W.H., 1961, Neuropathology, 475
  11. 10.1001/archneur.1991.00530210089029 · DOI
  12. Hauw J.J., 1995, Lacunar and Other Subcortical Infarctions, 3
  13. 10.1056/NEJM198611133152001 · DOI · Paper page
  14. Lanctôt K.L., 2003, Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta‐analysis, CMAJ, 169, 557
  15. 10.1016/S0955-0674(05)80038-9 · DOI
  16. 10.1111/j.1750-3639.1993.tb00725.x · DOI · Paper page
  17. 10.1146/annurev.med.57.121304.131442 · DOI · Paper page
  18. 10.1016/0092-8674(89)90093-7 · DOI
  19. 10.1186/1741-7015-7-7 · DOI · Paper page
  20. Ganguli M., 2011, Principles and Practice of Geriatric Psychiatry, 207
  21. 10.1016/S0022-510X(02)00252-6 · DOI · Paper page
  22. American Psychiatric Association, 1980, Diagnostic and statistical manual of mental diseases, version III
  23. World Health Organization, 1992, The ICD‐10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines
  24. American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
  25. American Psychiatric Association, 2011, APA DSM‐V
  26. 10.1176/jnp.2008.20.2.150 · doi:10.1176/jnp.2008.20.2.150 · Paper page
  27. 10.1176/jnp.2008.20.2.162 · doi:10.1176/jnp.2008.20.2.162 · Paper page
  28. 10.1159/000026254 · DOI
  29. 10.1001/archneur.57.2.191 · DOI · Paper page
  30. Lamar M., 2009, The dysexecutive syndrome associated with ischaemic vascular disease and related subcortical neuropathology: a Boston process approach, Behav Neurol, 22, 53, 10.1155/2010/505979 · DOI · Paper page
  31. 10.1111/j.1365-2796.2004.01388.x · DOI · Paper page
  32. 10.1097/WAD.0b013e3181a4485c · DOI
  33. 10.1016/j.neurobiolaging.2008.10.018 · DOI · Paper page
  34. 10.1001/archneur.65.5.593 · DOI · Paper page
  35. 10.4997/JRCPE.2011.121 · DOI
  36. 10.1097/01.JGP.0000231780.44684.7e · DOI
  37. 10.1161/STROKEAHA.110.605097 · DOI
  38. 10.1016/j.jns.2005.08.010 · DOI
  39. 10.1080/13854040500263583 · DOI
  40. 10.1136/jnnp.67.1.66 · DOI · Paper page
  41. 10.1212/WNL.44.7.1246 · DOI · Paper page
  42. 10.1080/09540260902962198 · DOI · Paper page
  43. 10.1007/s11916-005-0039-y · DOI
  44. 10.1016/j.jns.2010.08.038 · DOI
  45. 10.1111/j.1532-5415.1999.tb02571.x · DOI · Paper page
  46. 10.3233/JAD-2011-091402 · DOI · Paper page
  47. 10.1002/ana.22055 · DOI · Paper page
  48. 10.3233/JAD-2009-1180 · DOI · Paper page
  49. 10.1016/j.neurobiolaging.2008.09.011 · DOI · Paper page
  50. 10.1016/j.jcomdis.2011.04.004 · DOI · Paper page
  51. 10.1111/j.1460-9568.2011.07613.x · DOI · Paper page
  52. 10.1016/B978-0-444-53355-5.00015-4 · DOI · Paper page
  53. 10.2174/156720511795745302 · DOI
  54. Williams J.W., 2010, Preventing Alzheimer's disease and cognitive decline. Evidence report/technology assessment
  55. 10.1161/circ.106.25.3143 · DOI · Paper page
  56. 10.1177/014107680609900917 · doi:10.1177/014107680609900917
  57. 10.7326/0003-4819-55-1-33 · DOI · Paper page
  58. Libby P., 2011, Braunwald's Heart Disease—A Textbook of Cardiovascular Medicine [online version], 914
  59. 10.1161/01.STR.0000116869.64771.5A · DOI · Paper page
  60. 10.1038/ajh.2009.212 · DOI · Paper page
  61. 10.1097/HCO.0b013e3283383e2c · DOI
  62. 10.1038/nrendo.2010.228 · DOI · Paper page
  63. 10.2337/diacare.27.5.1047 · DOI · Paper page
  64. Nichols W.W., 2005, McDonald's blood flow in arteries: theoretical, experimental and clinical principles
  65. 10.1253/circj.CJ-10-0910 · DOI · Paper page
  66. Libby P., 2011, Braunwald's Heart Disease—A Textbook of Cardiovascular Medicine [online version], 897
  67. Lau D.C., 2009, Metabolic syndrome: perception or reality?, Curr Atheroscler Rep, 11, 264, 10.1007/s11883-009-0041-7 · DOI
  68. 10.1016/j.jns.2010.08.039 · DOI
  69. 10.3233/JAD-2010-091669 · DOI · Paper page
  70. 10.1038/oby.2010.59 · DOI · Paper page
  71. 10.2337/diacare.19.3.287 · DOI · Paper page
  72. 10.1093/ajcn/83.6.1237 · DOI · Paper page
  73. 10.1016/j.ecl.2004.12.001 · DOI
  74. 10.1038/hr.2010.9 · DOI · Paper page
  75. 10.1038/oby.2010.22 · DOI · Paper page
  76. 10.1038/ijo.2009.133 · DOI · Paper page
  77. 10.1080/07853890500383895 · DOI · Paper page
  78. 10.1002/msj.20212 · DOI · Paper page
  79. 10.1093/epirev/mxm002 · DOI · Paper page
  80. 10.1053/j.gastro.2010.04.056 · DOI · Paper page
  81. 10.1002/path.2912 · DOI · Paper page
  82. 10.7326/0003-4819-61-5-888 · DOI · Paper page
  83. 10.1016/S0735-1097(02)02051-X · DOI · Paper page
  84. 10.1161/CIRCULATIONAHA.108.816694 · DOI · Paper page
  85. 10.1161/CIRCULATIONAHA.104.475715 · DOI · Paper page
  86. 10.1007/s11883-011-0166-3 · DOI
  87. 10.1038/nrcardio.2010.222 · DOI · Paper page
  88. 10.1007/s11886-010-0136-3 · DOI
  89. 10.1001/archneurol.2010.297 · DOI · Paper page
  90. Lesser G.T., 2009, Serum lipids are related to Alzheimer's pathology in nursing home residents, Dement Geriatr Cogn Disord, 27, 42, 10.1159/000189268 · DOI
  91. 10.1007/s00011-009-0060-4 · DOI · Paper page
  92. 10.2741/3812 · DOI
  93. 10.1046/j.1365-2796.2003.01177.x · DOI · Paper page
  94. 10.1007/s11906-008-0029-7 · DOI · Paper page
  95. 10.1007/s11883-007-0009-4 · DOI
  96. 10.1007/s11906-010-0096-4 · DOI · Paper page
  97. 10.1038/nature05485 · DOI · Paper page
  98. 10.1056/NEJMra1011670 · DOI · Paper page
  99. Konkle B.A., 2011, Harrison's Principles of Internal Medicine
  100. Weitz J.I., 2011, Braunwald's Heart Disease—A Textbook of Cardiovascular Medicine [online version], 1844
  101. 10.1172/JCI27196 · DOI · Paper page
  102. Alessi M.C., 2008, Metabolic syndrome, haemostasis and thrombosis, Thromb Haemost, 99, 995, 10.1160/TH07-11-0682 · DOI · Paper page
  103. Palomo I., 2010, Pathophysiology of the proatherothrombotic state in the metabolic syndrome, Front Biosci (Schol Ed), 2, 194
  104. Steg P.G., 2011, Atherothrombosis and the role of antiplatelet therapy, J Thromb Haemost, 9, 325, 10.1111/j.1538-7836.2011.04277.x · DOI
  105. 10.1161/ATVBAHA.109.199448 · DOI
  106. 10.1042/CS20100094 · DOI · Paper page
  107. 10.1007/s00401-009-0501-8 · DOI · Paper page
  108. 10.3988/jcn.2011.7.1.1 · DOI · Paper page
  109. Magistretti P.J., 2000, Psychopharmacology–4th Generation of Progress
  110. 10.1016/S0079-6123(06)53007-9 · DOI · Paper page
  111. PaseMP HerbertA GrimaNA Pipingas A O'RourkeMF.Arterial stiffness as a cause of cognitive decline and dementia: a systematic review and meta‐analysis.Intern Med J(in press).
  112. 10.1111/j.1749-6632.1994.tb44398.x · DOI · Paper page
  113. 10.1007/s00401-011-0865-4 · DOI · Paper page
  114. 10.1007/s00401-009-0522-3 · DOI · Paper page
  115. 10.1007/s12035-010-8105-9 · DOI · Paper page
  116. Grammas P., 2011, Brain microvasculature and hypoxia‐related proteins in Alzheimer's disease, Int J Clin Exp Pathol, 4, 616
  117. 10.1007/s00018-009-0141-0 · DOI
  118. 10.1096/fj.11-0102ufm · DOI · Paper page
  119. 10.1111/j.1749-6632.2010.05760.x · DOI · Paper page
  120. Institute of Medicine, 2001, Crossing the Quality Chasm: a new health system for the 21st century
  121. 10.1377/hlthaff.2010.0696 · DOI
  122. 10.1016/S1474-4422(11)70072-2 · DOI · Paper page
  123. 10.1017/S0033291711000109 · DOI · Paper page

Cited by

Metadata

Authors
Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. Y., & Arnold, S. E.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2012-11-26
Volume
9
Issue
1
Pages
76-92
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W1994814164
Cited by
133
References
51
FWCI
9.84
Type
journal article
Language
en
Open access
green
Funders
  • Alzheimer's Diseases Coordinating Center
  • NIH (P30 AG010124)
  • Allen H. and Selma W. Berkman Charitable Trust

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.